Fortress Biotech, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $6.8M | $-46.0M | $-60.6M | $-86.6M | $-64.7M | $-46.5M | $-40.0M | $-84.1M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $403.0K | $1.0M | $2.2M | $3.1M | $2.6M | $2.3M | $1.9M | $1.4M |
| Amortization | $4.3M | $3.4M | $3.8M | $4.3M | — | $1.4M | $1.2M | — |
| Stock-Based Compensation | $28.7M | $32.6M | $17.0M | $23.0M | $19.5M | $13.5M | $13.2M | $15.0M |
| Net Cash from Operating Activities | $-65.8M | $-80.2M | $-128.2M | $-179.4M | $-116.5M | $-83.7M | $-95.0M | $-98.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $0 | $63.0K | $2.7M | $4.6M | $1.9M | $2.3M | $7.1M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $10.1M | $-15.0M | $-2.1M | $-22.9M | $40.5M | $-7.2M | $20.1M | $18.8M |
| Financing Activities | ||||||||
| Dividends Paid | $664.0K | $694.0K | $736.0K | $749.0K | $749.0K | $237.0K | $0 | — |
| Stock Repurchases | — | — | — | — | — | $70.0K | $0 | — |
| Net Cash from Financing Activities | $77.4M | $70.6M | $32.7M | $75.3M | $149.0M | $172.4M | $146.7M | $50.6M |
| Net Change in Cash | $21.8M | $-24.6M | $-97.6M | $-127.0M | $73.0M | $81.6M | $71.9M | $-29.4M |
| Free Cash Flow | — | $-80.2M | $-128.3M | $-182.1M | $-121.1M | $-85.6M | $-97.3M | $-105.9M |